Your browser doesn't support javascript.
loading
Comprehensive outcomes after Roux-en-Y gastric bypass with a near-complete 15-year follow-up.
Jawhar, Noura; Abi Mosleh, Kamal; Bartosiak, Katarzyna Z; Hage, Karl; Kennel, Kurt A; Mundi, Manpreet S; Kendrick, Michael L; Ghanem, Omar M.
Afiliación
  • Jawhar N; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Abi Mosleh K; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Bartosiak KZ; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Hage K; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Kennel KA; Division of Endocrinology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Mundi MS; Division of Endocrinology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Kendrick ML; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Ghanem OM; Department of Surgery, Mayo Clinic, Rochester, MN. Electronic address: ghanem.omar@mayo.edu.
Surgery ; 176(3): 586-594, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38769035
ABSTRACT

BACKGROUND:

Laparoscopic Roux-en-Y gastric bypass has a well-established safety and efficacy profile in the short and mid-term. Long-term outcomes remain limited in the literature, especially for follow-up periods of >10 years. The purpose of the study is to evaluate the long-term durability and safety of laparoscopic Roux-en-Y gastric bypass over a near-complete 15-year follow-up.

METHODS:

This is a single-center retrospective cohort study of patients who underwent primary laparoscopic Roux-en-Y gastric bypass between 2008 and 2009 with ≥14-year follow-up. Data collected and analyzed were weight loss, obesity-related medical condition resolution and recurrence, weight recurrence, complication rate, and mortality rate.

RESULTS:

A total of 264 patients were included. Patients were predominantly female (81.8%), and the mean age and preoperative body mass index were 48.5 ± 12.2 years and 44.9 ± 7.3 kg/m2, respectively. The maximum mean percentage total weight loss achieved at 1 year was 31.5% ± 5.7% and was consistently >20% throughout follow-up. Sustained resolution of obesity-related medical conditions was achieved with a remission rate of 60.8% for type 2 diabetes mellitus, 46.7% for denoted dyslipidemia, and 40% for hypertension. Obesity-related medical condition recurrence was observed with a recurrence rate of 24.1% for type 2 diabetes mellitus, 17.9% for hypertension, and 14.8% for denoted dyslipidemia. Significant factors associated with weight loss were maximum percentage total weight loss and preoperative type 2 diabetes mellitus. Over 15 years, the weight recurrence rate was 51.1%, with predictors of higher preoperative body mass index and preoperative type 2 diabetes mellitus.

CONCLUSION:

Laparoscopic Roux-en-Y gastric bypass provides sustainable weight loss over a 15-year period, with consistent long-term weight-loss outcomes and resolution of obesity-related medical conditions sustained for ≥10 years after surgery.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Obesidad Mórbida / Derivación Gástrica / Pérdida de Peso / Laparoscopía Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Surgery Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Obesidad Mórbida / Derivación Gástrica / Pérdida de Peso / Laparoscopía Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Surgery Año: 2024 Tipo del documento: Article